Occurrence and determinants of exposure to FDA class C, D, X drugs in pregnant women - Research proposal

Principal Investigator:

Dr Shi Wu Wen, University of Ottawa

Co-Investigator:

Dr Carl Nimrod, University of Ottawa
Dr William Fraser, University of Montreal
Dr Peter Garner, University of Ottawa
Olufemi Olatunbosun, University of Saskatchewan
Dr Mark Walker, University of Ottawa

Funding Agency:

PSI (THE PHYSICIANS' SERVICES INCORPORATED FOUNDATION)

Objectives:

To estimate the prevalence and analyze the determinants of pregnancy exposure to prescription drugs that are rated as FDA class C, D, X drugs in the general population.